R&D
Biomedical researchers discuss results

The reasoning problem

In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.

Digital
Ovarian cancer

Ovarian cancer, Olivia, and the OCC – part one

Following the European Society of Gynaecological Oncology (ESGO) 2022 congress, pharmaphorum spoke with experts from among the Ovarian Cancer Commitment (OCC) founding partners – ESGO, the

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Patients

R&D

R&D
Biomedical researchers discuss results

The reasoning problem

In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.